Release date: 2016-05-12
The AI ​​app is becoming the next important competitive area for tech giants like Facebook, Google, Apple, Microsoft, IBM and Amazon.
Market research firm IDC estimates that the market for machine learning apps could reach $40 billion by 2020, with 60% of applications running on the platforms of these tech giants. According to IDC estimates, only 1% of software applications now have the characteristics of artificial intelligence, but by 2018, this number is expected to reach 50%.
In Pedro Domingo's book The Master Algorithm – AI and Big Data Will Remake the World, the author mentions that anyone who wins this competition can rule the next phase of the information age. Mark Zuckerberg provided a clue to the future App. In a recent speech in April, he emphasized that the ability to connect people around the world to the Internet would benefit society as a whole.
Zuckerberg mentioned that one of the biggest benefits is to diagnose the disease earlier and faster. He mentioned an app he knew, with photos taken on smartphones and artificial intelligence enhancement algorithms developed by developers, which can diagnose skin cancer better than any doctor. For example, with this app, any doctor in the world can better diagnose melanoma. Zuckerberg said: The use of artificial intelligence to diagnose cancer, especially skin cancer, has emerged and will become one of the best applications for the Internet. Of course, he did not name the company that had attracted his attention.
Among the existing medical applications, there is an application that uses cloud artificial intelligence technology to perform "Total Body Photography" using a mobile phone camera to detect melanoma. The app, DermaCompare, is available for free download from the Apple Store and was developed by an Israeli company, Emerald Medical Applications (MRLA), and is registered with the FDA. The app is HIPPA (Health Insurance Circulation and Accountability Act, protecting patient privacy), said Lior Wayne, CEO of Emerald Medical, who downloaded the app and used a patent comparison algorithm that allows each user or doctor to pass any intelligence The camera of the phone to confirm if a certain sputum is a melanoma sign. Wayne believes that DermaCompare is the only skin cancer diagnostic application that uses artificial intelligence.
"DermaCompare is an application that allows patients to perform self-skin checks with a "full body photography (TBP)" shot with a simple digital camera," Wayne said. Users can download the app and explain it to any device with a digital camera.
Wayne explains that once a patient uploads his or her "full body photography" image to their private file on the DermaCompare cloud server for storage and preview, the DermaCompare platform will (1) map the image to any history in the patient file. The images are compared and the images associated with the company database are compared; (2) the patient's files are updated, a summary of data points is created, data relating to the patient's skin image is listed, and any suspected image changes are alerted. Information; (3) Notifying the relevant doctor to obtain and review the printed data chart and the whole body photographic image of the printed patient. It automatically matches 50 million known freckle images and historical images of patients in the cloud server. This technology greatly enhances the accuracy and speed of doctors' detection of melanoma.
Wayne claims that 60% of melanomas are found on new sputum, and another 40% are found on lesions. Therefore, it is useful to take pictures of the growth of melanoma, which is what physicians are doing through whole body photography. "The problem is time, money, accuracy, and whether the patient is in contact, because the only means of comparing images is the naked eye and the human hand, which is what makes this application a reality," Wayne said. "Based on Israeli military technology, we Use machine learning, big data and artificial intelligence to prevent melanoma and other skin diseases."
"The world's technology giants have never been so strong about Israeli technology," said Itzack Shrem, founder of Israel's largest hedge fund. He also invested in Emerald himself. "I agree with Mark Zuckerberg about the idea that artificial intelligence medical applications will dominate the next technology trend, and I believe Emerald will be one of the most important and influential companies in the field," Shrem said.
Competing for R&D to provide free services with valuable services, this competition is even more profitable for the major tech giants, Emerald's Lior Wayne said he noticed that Google's $1.3 billion acquisition of waze has become The mainstay of Google Maps business. Whats App, which Facebook acquired for $19 billion, will emerge in the next round of competitions for new service areas, and may become the most downloaded free application for medical use, like Waze and Whats App, DermaCompare is also a Israeli technology company.
The technology developed by Emerald comes from the artificial intelligence image comparison technology of the Israeli Ministry of Defense based on cloud computing, Wayne said. Emerald now uses Microsoft's cloud service to provide free application services, and the company's profitability is to provide doctors with pictures as part of a paid "full body photography" service.
Source: Heart of the Machine Synced
The best choice for Analog hearing aids with earbuds design
The best choice for Analog hearing aids with earbuds design
Shenzhen Sunshine Technology Co.,Ltd , https://www.yatwinsz.com